Sanofi
SNY
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, otā¦ read more
Healthcare
Drug ManufacturersāGeneral
23 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$46.51
Price+0.79%
$0.37
1Y
Price
Market Cap
$112.956b
Large
Price/Earnings 3y Avg5y Avg
19.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in EUR.+31.3%
EBITDA Margin-6.6%
Net Profit Margin+13.0%
Free Cash Flow Margin+31.3%
EBITDA Margin-6.6%
Net Profit Margin+13.0%
Free Cash Flow MarginRevenue
$46.716b
+5.5%
1y CAGR+4.8%
3y CAGR+4.5%
5y CAGREarnings
$7.813b
+40.5%
1y CAGR+2.7%
3y CAGR+10.6%
5y CAGREPS
$2.03
-6.8%
1y CAGR-12.5%
3y CAGR-2.4%
5y CAGRBook Value
$71.710b
$126.806b
Assets$55.096b
Liabilities$21.787b
DebtDebt to Assets
17.2%
1.6x
Debt to EBITDAFree Cash Flow
$8.892b
+40.6%
1y CAGR+4.2%
3y CAGR+2.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company